Biocompatibility and Biostability of Metallic Endovascular Implants: State of the Art and Perspectives

Journal of Endovascular Therapy

Volumn 10, Issue 4, 2003, Pages 807-824

  Thierry, Benjamin ^a   Tabrizian, Maryam ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Biocompatibility; Biostability; Corrosion; Elgiloy; Metals; Nitinol; Restenosis; Stainless steel; Stents

Indexed keywords

ALLOY; BIOMATERIAL; METAL; NITINOL; POLITEF; STAINLESS STEEL; TANTALUM;

ANIMAL; BIOCOMPATIBILITY; BIODEGRADATION; BLOOD; BLOOD VESSEL PROSTHESIS; CELL MIGRATION; CELL PROLIFERATION; CORROSION; DEGRADATION; DEVICE; ENDOVASCULAR SURGERY; HUMAN; IMPLANT; PRIORITY JOURNAL; PROSTHESIS FAILURE; RECURRENT DISEASE; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; STENT; SURFACE PROPERTY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; BLOOD VESSEL PROSTHESIS; CORROSION; HUMANS; METALS; PROSTHESIS FAILURE; RECURRENCE; SURFACE PROPERTIES;

EID: 0242331797     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2003)010<0807:BABOME>2.0.CO;2     Document Type: Review

References (116)

1. Thierry B, Merhi Y, Bilodeau L, et al. Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model. Biomaterials. 2002;23:2997-3005.
2. Chwirut DJ, Oktay HS, Ryan T. Nitinol interventional cardiology devices-FDA's perspective. In: Pelton A, Hodgson D, Russell S, et al., eds. SMST 97: Proceedings of the Second International Conference on Shape Memory and Superelastic Technologies. Santa Clara, CA: SMST; 1997.
3. Disegi J, Zardiackas L. Retrieval analysis of stainless steel plate/screws implanted for 55 years [Abstract]. In: Proceeding of the 27th Meeting of the Society for Biomaterials. Mt. Laurel, NJ: Society for Biomaterials; 2000.
4. Guidoin R, Marois Y, Douville Y, et al. First-generation aortic endografts: analysis of explanted Stentor devices from the EUROSTAR registry. J Endovasc Ther. 2000;7:105-122.
5. Heintz C, Riepe G, Birken L, et al. Corroded nitinol wires in explanted aortic endografts: an important mechanism of failure? J Endovasc Ther. 2001;8:248-253.
6. Koster R, Vieluf D, Kiehn M, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet. 2000;356:1895-1897.
7. Kastrati A, Schomig A, Dirschinger J, et al. Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation. 2000;101:2478-2483.
8. Edelman ER, Seifert P, Groothuis A, et al. Gold-coated NIR stents in porcine coronary arteries. Circulation. 2001;103:429-434.
9. Venugopalan R, Trépanier C. Assessing the corrosion behaviour of nitinol for minimally-invasive device design. Minim Invasive Ther Allied Technol. 2000;9:67-74.
10. Gershlick AH. Role of stenting in coronary revascularisation. Heart. 2001;86:104-112.
11. Narins CR, Ellis SG. Prevention of in-stent restenosis. Semin Interv Cardiol. 1998;3:91-103.
12. Stoeckel D. Nitinol medical devices and implants. Minim Invasive Ther Allied Technol. 2000;9:81-88.
13. Pelton AR, DiCello J, Miyazaki S. Optimisation of processing and properties of medical grade nitinol wire. Minim Invasive Ther Allied Technol. 2000;9:107-118.
14. Bhargava B, De Scheerder I, Ping QB, et al. A novel platinum-iridium, potentially gamma radioactive stent: evaluation in a porcine model. Catheter Cardiovasc Interv. 2000;51:364-368.
15. van Dijk LC, van Holten J, van Dijk BP, et al. A precious metal alloy for construction of MR imaging-compatible balloon-expandable vascular stents. Radiology. 2001;219:284-287.
16. Manke C, Nitz WR, Lenhart M, et al. Magnetic resonance monitoring of stent deployment: in vitro evaluation of different stent designs and stent delivery systems. Invest Radiol. 2000;35:343-351.
17. Maintz D, Fischbach R, Juergens KU, et al. Multislice CT angiography of the iliac arteries in the presence of various stents: in vitro evaluation of artifacts and lumen visibility. Invest Radiol. 2001;36:699-704.
18. Heublein B, Rohde R, Kaese V, et al. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart. 2003;89:651-656.
19. Peuster M, Wohlsein P, Brugmann M, et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart. 2001;86:563-569.
20. ASTM F86. Standard Practice for Surface Preparation and Marking of Metallic Surgical Implants. In: Annual Book of ASTM Standards: Medical Devices and Services, Vol. 13.01. Philadelphia: American Society for Testing and Materials; 1995:6-8.
21. Trépanier C, Tabrizian M, Yahia LH, et al. Effect of modification of oxide layer on NiTi stent corrosion resistance. J Biomed Mater Res. 1998;43:433-440.
22. De Scheerder I, Verbeken E, Van Humbeeck J. Metallic surface modification. Semin Interv Cardiol. 1998;3:139-144.
23. Clark GC, Williams DF. The effects of proteins on metallic corrosion. J Biomed Mater Res. 1982;16:125-134.
24. Khan MA, Williams RL, Williams DF. The corrosion behaviour of Ti-6AI-4V, Ti-6AI-7Nb and Ti-13Nb-13Zr in protein solutions. Biomaterials. 1999;20:631-637.
25. Wataha JC, Nelson SK, Lockwood PE. Elemental release from dental casting alloys into biological media with and without protein. Dent Mater. 2001;17:409-414.
26. Milosev I, Strehblow HH. The behavior of stainless steels in physiological solution containing complexing agent studied by X-ray photoelectron spectroscopy. J Biomed Mater Res. 2000;52:404-412.
27. Mu Y, Kobayashi T, Sumita M, et al. Metal ion release from titanium with active oxygen species generated by rat macrophages in vitro. J Biomed Mater Res. 2000;49:238-243.
28. Hutchinson BS, Baumgardner JD. Evaluation of the effect of cells on the corrosion behavior of implant alloys [Abstract]. In: Proceedings of the World Biomaterials Congress. Mt. Laurel, NJ: Society for Biomaterials; 2000.
29. Woodman JL, Black J, Jiminez SA. Isolation of serum protein organometallic corrosion products from 316LSS and HS-21 in vitro and in vivo. J Biomed Mater Res. 1984;18:99-114.
30. Jacobs JJ, Skipor AK, Patterson LM, et al. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am. 1998;80:1447-1458.
31. Ryan MP, Williams DE, Chater RJ, et al. Why stainless steel corrodes. Nature. 2002;415:770-774.
32. Wang YZ. Corrosion fatigue. In: Revie RW, ed. Uhlig's Corrosion Handbook. 2nd ed. Chichester, UK: Wiley; 2000:221-232.
33. Emanuelli G, Gatti AM, Cigada A, et al. Physico-chemical observations on a failed Greenfield vena cava filter. J Cardiovasc Surg (Torino). 1995;36:121-125.
34. McKelvey AL, Ritchie RO. Fatigue-crack propagation in Nitinol, a shape-memory and superelastic endovascular stent material. J Biomed Mater Res. 1999;47:301-308.
35. Reclaru L, Lerf R, Eschler PY, et al. Pitting, crevice and galvanic corrosion of REX stainless-steel/CoCr orthopedic implant material. Biomaterials. 2002;23:3479-3485.
36. ASTM G5. Standard Reference Test Method for Making Potentiostatic and Potentiodynamic Anodic Polarization Measurements. In: Annual Book of ASTM Standards: Metals, Test Methods and Analytical Procedures. Philadelphia: American Society for Testing and Materials; 1995:48-58.
37. ASTM G102. Standard Practice for Calculation of Corrosion Rates and Related Information From Electrochemical Measurements. In: Annual Book of ASTM Standards: Metals, Test Methods and Analytical Procedures. Philadelphia: American Society for Testing and Materials; 1995:401-407.
38. ASTM F746. Standard Test Method for Pitting or Crevice Corrosion of Metallic Surgical Implant Materials. In: Annual Book of ASTM Standards: Metals, Test Methods and Analytical Procedures. Philadelphia: American Society for Testing and Materials; 1995:192-197.
39. Trépanier C, Venugopalan R, Messer R, et al. Effect of passivation treatments on nickel release from nitinol [Abstract]. In: Proceeding of the World Biomaterials Congress. Mt. Laurel, NJ: Society for Biomaterials; 2000.
40. Fili P, Lausmaa J, Musialek J, et al. Structure and surface of TiNi human implants. Biomaterials. 2001;22:2131-2138.
41. Thierry B, Tabrizian M, Trépanier C, et al. Effect of surface treatment and sterilization processes on the corrosion behavior of NiTi shape memory alloy. J Biomed Mater Res. 2000;51:685-693.
42. Ryhanen J, Niemi E, Serlo W, et al. Biocompatibility of nickel-titanium shape memory metal and its corrosion behavior in human cell cultures. J Biomed Mater Res. 1997;35:451-457.
43. Wever DJ, Veldhuizen AG, de Vries J, et al. Electrochemical and surface characterization of a nickel-titanium alloy. Biomaterials. 1998;19:761-769.
44. Rondelli G. Corrosion resistance tests on NiTi shape memory alloy. Biomaterials. 1996;17:2003-2008.
45. Venugopalan R. Corrosion testing of stents: a novel fixture to hold entire device in deployed form and finish. J Biomed Mater Res. 1999;48:829-832.
46. Clerc CO, Jedwab MR, Mayer DW, et al. Assessment of wrought ASTM F1058 cobalt alloy properties for permanent surgical implants. J Biomed Mater Res. 1997;38:229-234.
47. Gotman I. Characteristics of metals used in implants. J Endourol. 1997;11:383-389.
48. Garasic JM, Edelman ER, Squire JC, et al. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation. 2000;101:812-818.
49. Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001;103:2816-2821.
50. Hoffmann R, Jansen C, Konig A, et al. Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study. Eur Heart J. 2001;22:2007-2014.
51. Yoshitomi Y, Kojima S, Yano M, et al. Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents. Am Heart J. 2001;142:445-451.
52. Kastrati A, Mehilli J, Dirschinger J, et al. Restenosis after coronary placement of various stent types. Am J Cardiol. 2001;87:34-39.
53. Gunn J, Cumberland D. Does stent design influence restenosis? Eur Heart J. 1999;20:1009-1013.
54. Dyet JF, Watts WG, Ettles DF, et al. Mechanical properties of metallic stents: how do these properties influence the choice of stent for specific lesions? Cardiovasc Intervent Radiol. 2000;23:47-54.
55. Sheth S, Litvack F, Dev V, et al. Subacute thrombosis and vascular injury resulting from slotted-tube nitinol and stainless steel stents in a rabbit carotid artery model. Circulation. 1996;94:1733-1740.
56. Carter AJ, Scott D, Laird JR, et al. Progressive vascular remodeling and reduced neointimal formation after placement of a thermoelastic self-expanding nitinol stent in an experimental model. Cathet Cardiovasc Diagn. 1998;44:193-201.
57. Harnek J, Zoucas E, Carlemalm E, et al. Differences in endothelial injury after balloon angioplasty, insertion of balloon-expanded stents or release of self-expanding stents: an electron microscopic experimental study. Cardiovasc Intervent Radiol. 1999;22:56-61.
58. Yu ZX, Tamai H, Kyo E, et al. Comparison of the self-expanding Radius stent and the balloon-expandable Multilink stent for elective treatment of coronary stenoses: a serial analysis by intravascular ultrasound. Catheter Cardiovasc Interv. 2002;56:40-45.
59. Roguin A, Grenadier E, Linn S, et al. Continued expansion of the nitinol self-expanding coronary stent: angiographic analysis and 1-year clinical follow-up. Am Heart J. 1999;138:326-333.
60. Taylor AJ, Gorman PD, Kenwood B, et al. A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine model. Catheter Cardiovasc Interv. 2001;53:420-425.
61. Mukherjee D, Kalahasti V, Roffi M, et al. Self-expanding stents for carotid interventions: comparison of nitinol versus stainless-steel stents. J Invasive Cardiol. 2001;13:732-735.
62. Brash JL. Exploiting the current paradigm of blood-material interactions for the rational design of blood-compatible materials. J Biomater Sci Polym Ed. 2000;11:1135-1146.
63. Ratner BD. Blood compatibility - a perspective. J Biomater Sci Polym Ed. 2000;11:1107-1119.
64. Eto K, Goto S, Shimazaki T, et al. Two distinct mechanisms are involved in stent thrombosis under flow conditions. Platelets. 2001;12:228-235.
65. Janatova J. Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. ASAIO J. 2000;46:S53-62.
66. Basmadjian D, Sefton MV, Baldwin SA. Coagulation on biomaterials in flowing blood: some theoretical considerations. Biomaterials. 1997;18:1511-1522.
67. Vogler EA. Water and the acute biological response to surfaces. J Biomater Sci Polym Ed. 1999;10:1015-1045.
68. Simon C, Palmaz JC, Sprague EA. Protein interactions with endovascular prosthetic surfaces. J Long Term Eff Med Implants. 2000;10:127-141.
69. Park JY, Gemmell CH, Davies JE. Platelet interactions with titanium: modulation of platelet activity by surface topography. Biomaterials. 2001;22:2671-2682.
70. Sprague EA, Palmaz JC, Simon C, et al. Electrostatic forces on the surface of metals as measured by atomic force microscopy. J Long Term Eff Med Implants. 2000;10:111-125.
71. Williams DF. Biomaterials and biocompatibility: an introduction. In: Williams DF, ed. Fundamental Aspects of Biocompatibility. Boca Raton: CRC Press; 1981:2-3.
72. Ryhanen J, Kallioinen M, Tuukkanen J, et al. In vivo biocompatibility evaluation of nickel-titanium shape memory metal alloy: muscle and perineural tissue responses and encapsule membrane thickness. J Biomed Mater Res. 1998;41:481-488.
73. Matsuno H, Yokoyama A, Watari F, et al. Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials. 2001;22:1253-1262.
74. Trépanier C, Leung TK, Tabrizian M, et al. Preliminary investigation of the effects of surface treatments on biological response to shape memory NiTi stents. J Biomed Mater Res. 1999;48:165-171.
75. Formichi M, Marois Y, Roby P, et al. Endovascular repair of thoracic aortic aneurysm in dogs: evaluation of a nitinol-polyester self-expanding stent-graft. J Endovasc Ther. 2000;7:47-67.
76. Geary RL, Nikkari ST, Wagner WD, et al. Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg. 1998;27:96-108.
77. Vahey JW, Simonian PT, Conrad EU. Carcinogenicity and metallic implants. Am J Orthop. 1995;24:319-324.
78. Shih CC, Shih CM, Chen YL, et al. Growth inhibition of cultured smooth muscle cells by corrosion products of 316 L stainless steel wire. J Biomed Mater Res. 2001;57:200-207.
79. Shih CC, Lin SJ, Chen YL, et al. The cytotoxicity of corrosion products of nitinol stent wire on cultured smooth muscle cells. J Biomed Mater Res. 2000;52:395-403.
80. Wataha JC, O'Dell NL, Singh BB, et al. Relating nickel-induced tissue inflammation to nickel release in vivo. J Biomed Mater Res. 2001;58:537-544.
81. Uo M, Watari F, Yokoyama A, et al. Dissolution of nickel and tissue response observed by X-ray scanning analytical microscopy. Biomaterials. 1999;20:747-755.
82. Schmalz G, Schuster U, Schweikl H. Influence of metals on IL-6 release in vitro. Biomaterials. 1998;19:1689-1694.
83. Wataha JC, Lockwood PE, Marek M, et al. Ability of Ni-containing biomedical alloys to activate monocytes and endothelial cells in vitro. J Biomed Mater Res. 1999;45:251-257.
84. Wataha JC, Ratanasathien S, Hanks CT, et al. In vitro IL-1 beta and TNF-alpha release from THP-1 monocytes in response to metal ions. Dent Mater. 1996;12:322-327.
85. Budinger L, Hertl M. Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy. 2000;55:108-115.
86. Thomssen H, Hoffmann B, Schank M, et al. Cobalt-specific T lymphocytes in synovial tissue after an allergic reaction to a cobalt alloy joint prosthesis. J Rheumatol. 2001;28:1121-1128.
87. Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am. 2001;83-A:428-436.
88. Gimenez-Arnau A, Riambau V, Serra-Baldrich E, et al. Metal-induced generalized pruriginous dermatitis and endovascular surgery. Contact Dermatitis. 2000;43:35-40.
89. Rensing BJ, Vos J, Smits PC, et al. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J. 2001;22:2125-2130.
90. Heldman AW, Cheng L, Jenkins GM, et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation. 2001;103:2289-2295.
91. Fox R. American Heart Association 2001 scientific sessions: late-breaking science-drug-eluting stents. Circulation. 2001;104:E9052.
92. Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation. 2001;104:2007-2011.
93. Drachman DE, Simon DI. Restenosis: intracoronary brachytherapy. Curr Treat Options Cardiovasc Med. 2002;4:109-118.
94. Waksman R, Raizner AE, Yeung AC, et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet. 2002;359:551-557.
95. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol. 2002;39:183-193.
96. Serruys PW, Kay IP. I like the candy, I hate the wrapper: the (32)P radioactive stent. Circulation. 2000;101:3-7.
97. Albiero R, Colombo A. European high-activity (32)P radioactive stent experience. J Invasive Cardiol. 2000;12:416-421.
98. Liistro F, Gimelli G, Di Mario C, et al. Late acute thrombosis after coronary brachytherapy: when is the risk over? Catheter Cardiovasc Interv. 2001;54:216-218.
99. Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart. 2001;86:262-264.
100. Brenner DJ, Miller RC. Long-term efficacy of intracoronary irradiation in inhibiting in-stent restenosis. Circulation. 2001;103:1330-1332.
101. Liistro F, Stankovic G, Di Mario C, et al. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation. 2002;105:1883-1886.
102. Lewis AL, Cumming ZL, Goreish HH, et al. Crosslinkable coatings from phosphorylcholine-based polymers. Biomaterials. 2001;22:99-111.
103. Lewis AL, Tolhurst LA, Stratford PW. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials. 2002;23:1697-1706.
104. Grenadier E, Roguin A, Hertz I, et al. Stenting very small coronary narrowings (<2 mm) using the biocompatible phosphorylcholine-coated coronary stent. Catheter Cardiovasc Interv. 2002;55:303-308.
105. Nelson SR, deSouza NM, Allison DJ. Endovascular stents and stent-grafts: is heparin coating desirable? Cardiovasc Intervent Radiol. 2000;23:252-255.
106. Vrolix MC, Legrand VM, Reiber JH, et al. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol. 2000;86:385-389.
107. van der Giessen WJ, van Beusekom HM, Eijgelshoven MH, et al. Heparin-coating of coronary stents. Semin Interv Cardiol. 1998;3:173-176.
108. Kocsis JF, Llanos G, Holmer E. Heparin-coated stents. J Long Term Eff Med Implants. 2000;10:19-45.
109. Lahann J, Klee D, Pluester W, et al. Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices. Biomaterials. 2001;22:817-826.
110. Nan H, Ping Y, Xuan C, et al. Blood compatibility of amorphous titanium oxide films synthesized by ion beam enhanced deposition. Biomaterials. 1998;19:771-776.
111. Gutensohn K, Beythien C, Bau J, et al. In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb Res. 2000;99:577-585.
112. Heublein B, Özbek C, Pethig K. Silicon carbide-coated stents: clinical experience in coronary lesions with increased thrombotic risk. J Endovasc Surg. 1998;5:32-36.
113. Windecker S, Mayer I, De Pasquale G, et al. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia. Circulation. 2001;104:928-933.
114. Yasuda S, Noguchi T, Gohda M, et al. Local delivery of low-dose docetaxel, a novel microtubule polymerizing agent, reduces neointimal hyperplasia in a balloon-injured rabbit iliac artery model. Cardiovasc Res. 2002;53:481-486.
115. Sturek M, Reddy HK. New tools for prevention of restenosis could decrease the "oculostento" reflex. Cardiovasc Res. 2002;53:292-293.
116. Suzuki T, Hayase M, Hibi K, et al. Effect of local delivery of L-arginine on in-stent restenosis in humans. Am J Cardiol. 2002;89:363-367.